Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Lim J, Crespo-Barreto J, Jafar-Nejad P, Bowman AB, Richman R, Hill DE, Orr HT, Zoghbi HY (2008) Nature 452: 713-8 Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes. Bowman AB, Lam YC, Jafar-Nejad P, Chen HK, Richman R, Samaco RC, Fryer JD, Kahle JJ, Orr HT, Zoghbi HY (2007) Nat Genet 39: 373-9 ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Lam YC, Bowman AB, Jafar-Nejad P, Lim J, Richman R, Fryer JD, Hyun ED, Duvick LA, Orr HT, Botas J, Zoghbi HY (2006) Cell 127: 1335-47 Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Bowman AB, Yoo SY, Dantuma NP, Zoghbi HY (2005) Hum Mol Genet 14: 679-91 Genetic modifiers of neurological disease. Kearney JA (2011) Curr Opin Genet Dev 21: 349-53 Adult-onset spinocerebellar ataxia syndromes due to MTATP6 mutations. Pfeffer G, Blakely EL, Alston CL, Hassani A, Boggild M, Horvath R, Samuels DC, Taylor RW, Chinnery PF (2012) J Neurol Neurosurg Psychiatry 83: 883-6 Diffusion tensor imaging reveals disease-specific deep cerebellar nuclear changes in cerebellar degeneration. Du AX, Cuzzocreo JL, Landman BA, Zee DS, Prince JL, Ying SH (2010) J Neurol 257: 1406-8 MRI shows a region-specific pattern of atrophy in spinocerebellar ataxia type 2. Jung BC, Choi SI, Du AX, Cuzzocreo JL, Ying HS, Landman BA, Perlman SL, Baloh RW, Zee DS, Toga AW, Prince JL, Ying SH (2012) Cerebellum 11: 272-9
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.